Avience Biomedicals SME IPO Subscription Status
Avience Biomedicals SME IPO closed on 22 June 2026 with an overall subscription of 385.40x based on shares applied. QIB demand came in at 196.77x, NII at 597.63x, and retail at 401.36x.
Allotment will be finalised on 23 June 2026. The stock is scheduled to list on NSE and BSE on 25 June 2026.
Issue Price
Rs 208.00
GMP Today
Rs 145.00 (+69.71%)
Overall Subscription
385.40x
Issue Size
₹30.24 Cr
Allotment Date
23 Jun 2026
Listing Date
25 Jun 2026
Avience Biomedicals SME IPO Subscription by Amount
Category-wise subscription based on amount applied at issue price Rs 208.00
| Category | Amount Offered | Amount Applied | Subscription |
|---|---|---|---|
| QIB | Rs 5.69 Cr | Rs 1,119.82 Cr | 196.77x |
| FII | - | Rs 195.21 Cr | - |
| DFI | - | Rs 139.51 Cr | - |
| Mutual Funds | - | Rs 18.70 Cr | - |
| Other | - | Rs 766.40 Cr | - |
| NII | Rs 4.31 Cr | Rs 2,573.16 Cr | 597.63x |
| bNII (above Rs 10L) | Rs 2.87 Cr | Rs 1,925.39 Cr | 670.77x |
| Corporate | - | Rs 22.94 Cr | - |
| Individual | - | Rs 1,888.74 Cr | - |
| Other | - | Rs 13.72 Cr | - |
| sNII (Rs 2L to Rs 10L) | Rs 1.44 Cr | Rs 647.77 Cr | 451.35x |
| Corporate | - | Rs 5.07 Cr | - |
| Individual | - | Rs 634.26 Cr | - |
| Other | - | Rs 8.45 Cr | - |
| IND | Rs 10.01 Cr | Rs 4,017.16 Cr | 401.36x |
| Total | Rs 20.01 Cr | Rs 7,710.14 Cr | 385.40x |
Avience Biomedicals SME IPO Subscription by Applications
Category-wise subscription based on applications received
| Category | Applications Offered | Applications Received | Subscription |
|---|---|---|---|
| QIB | 456 | 172 | 0.38x |
| FII | - | 23 | - |
| DFI | - | 80 | - |
| Mutual Funds | - | 3 | - |
| Other | - | 66 | - |
| NII | 115 | 31,836 | 276.83x |
| bNII (above Rs 10L) | 77 | 16,492 | 214.18x |
| Corporate | - | 181 | - |
| Individual | - | 16,193 | - |
| Other | - | 118 | - |
| sNII (Rs 2L to Rs 10L) | 38 | 15,344 | 403.79x |
| Corporate | - | 133 | - |
| Individual | - | 14,995 | - |
| Other | - | 216 | - |
| IND | 401 | 1,60,944 | 401.36x |
| Total | 972 | 1,92,952 | 198.51x |
What Do These Subscription Numbers Mean?
A subscription of 385.40x by shares means the IPO received bids for 385 times the shares reserved. Allotment odds depend on application count in each category, not share volume.
Here is what each category number tells you:
QIB at 196.77x by shares: This is the strongest signal on the page. QIBs are institutional investors, mutual funds, foreign institutions, and banks. When they subscribe at 196.77x, it reflects serious institutional conviction.
NII at 276.83x by applications: NII includes high net worth individuals applying above Rs 2 lakh. Proportional allotment uses application subscription. bNII came in at 214.18x and sNII at 403.79x by applications. Share subscription was 597.63x. Allotment uses application count, not share volume.
At 401.36x subscription by applications, approximately 1 in 401 retail applicants can expect an allotment (~1% per application). Retail allotment is done by lottery when oversubscribed.
Avience Biomedicals SME IPO Allotment Chances
Allotment odds below use application subscription (number of bids received), not share or amount subscribed.
Retail (IND)
- •Application subscription: 401.36x.
- •Allotment odds: about 1 in 401 (~1% chance per application).
- •Method: Lottery. If allotted, you receive at least one lot.
- •One application per PAN. Multiple eligible accounts in a household can improve overall family odds, not individual odds.
SHNI (Rs 2 lakh to Rs 10 lakh)
- •Application subscription: 403.79x.
- •Allotment odds: about 1 in 404 for a minimum-lot application (~1% of the applied lot on average).
- •Method: Proportional. Shares allotted are based on your bid size, not a lottery.
- •Share subscription was 451.35x. Allotment uses application count, not share volume.
BHNI (above Rs 10 lakh)
- •Application subscription: 214.18x.
- •Allotment odds: about 1 in 214 for a minimum-lot application (~1% of the applied lot on average).
- •Method: Proportional. Shares allotted are based on your bid size, not a lottery.
- •Share subscription was 670.77x. Allotment uses application count, not share volume.
Check the Avience Biomedicals SME IPO Allotment Status page from 23 June 2026 for your allotment result.
Avience Biomedicals SME IPO GMP After Subscription
GMP for Avience Biomedicals SME stands at Rs 145.00 today, giving an estimated listing price of Rs 353.00 per share.
A subscription of 385.40x combined with a GMP of 69.71% is a strong combination heading into listing. QIB demand above 50x in particular tends to support listing sentiment, as institutional investors are seen as informed buyers.
Track live GMP on the Avience Biomedicals SME IPO GMP Today page or the IPOwiz Live IPO GMP Tracker.
Avience Biomedicals SME IPO Day-wise Subscription
| Day | QIB | NII | Retail | Overall |
|---|---|---|---|---|
| Day 1 - 18 Jun 2026 | 0.00x | 13.49x | 15.69x | 10.75x |
| Day 2 - 19 Jun 2026 | 0.03x | 66.36x | 58.97x | 43.79x |
| Day 3 - 22 Jun 2026 | 196.77x | 597.23x | 401.21x | 385.24x |
Avience Biomedicals SME IPO Key Dates
| Event | Date |
|---|---|
| IPO Open Date | 18 June 2026 |
| IPO Close Date | 22 June 2026 |
| Allotment Date | 23 June 2026 |
| Refund Initiation | 24 June 2026 |
| Share Credit to Demat | 24 June 2026 |
| Listing Date | 25 June 2026 |
| Minimum Investment | Rs 2,49,600.00 |
| Lot Size | 600 shares |
About Avience Biomedicals SME
Avience Biomedicals Limited, incorporated in June 2024, is an ISO-certified healthcare and biotechnology solutions company. The enterprise specializes in manufacturing, supplying, and exporting high-precision molecular diagnostic formulations, in-vitro diagnostics (IVD) rapid test kits, serology products, and automated biochemistry and hematology analyzers. Operating entirely on business-to-business (B2B) and business-to-government (B2G) frameworks, Avience provides cost-effective diagnostics to premier hospital networks, pathology labs, and research institutions.
Understanding Subscription Categories
QIB - Qualified Institutional Buyers
Includes foreign institutional investors, domestic financial institutions, mutual funds, and other qualified institutions. QIB demand is considered the most reliable indicator of institutional confidence in an IPO.
NII - Non-Institutional Investors
High net worth individuals applying above Rs 2 lakh. Divided into bNII (above Rs 10 lakh) and sNII (Rs 2 lakh to Rs 10 lakh). NII allotment is proportional.
IND - Individual Investors
Investors applying up to Rs 2 lakh per PAN. Allotment is by lottery when oversubscribed. Minimum one lot per successful applicant.
Avience Biomedicals SME IPO GMP Today
Live GMP, listing price estimate, and listing gain
Avience Biomedicals SME IPO Allotment Status
Check allotment result on allotment date
Avience Biomedicals SME IPO Details
Financials, peers, strengths, and review
All IPO Subscription Status
Subscription for all active IPOs
Avience Biomedicals SME IPO Subscription FAQs
What is Avience Biomedicals SME IPO subscription status today?
Avience Biomedicals SME IPO subscription closed on 22 June 2026 with overall subscription of 385.40x (by shares) as of 18 July 2026, 6:01 PM IST. QIB 196.77x, NII 276.83x, IND 401.36x.
What is the overall subscription of Avience Biomedicals SME IPO?
Avience Biomedicals SME IPO is subscribed 385.40x overall by shares at close on 22 June 2026. QIB 196.77x, NII 276.83x, and IND 401.36x.
What is Avience Biomedicals SME IPO QIB subscription?
Avience Biomedicals SME IPO QIB (Qualified Institutional Buyers) subscription is 196.77x by shares. QIB includes mutual funds, FIIs, banks, and other institutions.
What is Avience Biomedicals SME IPO IND subscription?
Avience Biomedicals SME IPO IND subscription is 401.36x by applications. Minimum retail bid is up to Rs 2 lakh per PAN.
What is Avience Biomedicals SME IPO NII subscription?
Avience Biomedicals SME IPO NII (Non-Institutional Investors) subscription is 276.83x by applications. NII covers bids above Rs 2 lakh.
What are allotment chances in Avience Biomedicals SME IPO for retail?
At 401.36x subscription by applications, approximately 1 in 401 retail applicants can expect an allotment (~1% per application). Allotment is done by lottery.
When is Avience Biomedicals SME IPO allotment date?
Avience Biomedicals SME IPO allotment date is 23 June 2026. Check Avience Biomedicals SME IPO Allotment Status on IPOwiz from that day using your PAN.
When does Avience Biomedicals SME IPO subscription close?
Avience Biomedicals SME IPO subscription closed on 22 June 2026. No new applications are accepted after the close.
What is Avience Biomedicals SME IPO GMP today?
Avience Biomedicals SME IPO GMP is ₹145 today (+69.71% over issue price ₹208). See live GMP on the Avience Biomedicals SME IPO GMP Today page.
What is Avience Biomedicals SME IPO issue price and lot size?
Avience Biomedicals SME IPO issue price is ₹208 per share. Lot size is 600 shares. Minimum investment is ₹2,49,600 per lot (minimum 2 lots for SME). Issue size: ₹30.24 Cr.
When is Avience Biomedicals SME IPO listing date?
Avience Biomedicals SME IPO listing date is 25 June 2026 on NSE and BSE. Allotment is on 23 June 2026.
How does subscription affect Avience Biomedicals SME IPO allotment?
Allotment odds in Avience Biomedicals SME IPO depend on application subscription in each category, not share volume. Retail uses lottery when oversubscribed. NII proportional allotment at 276.83x by applications means roughly 1 in 277 for minimum-lot bids; bNII at 214.18x (~1 in 214). At 385.40x overall, competition is very high.
For allotment results from 23 June 2026, visit the Avience Biomedicals SME IPO Allotment Status page. For listing day updates on 25 June 2026, download the IPOwiz App.
Reviewed by Dinesh Agrawal
15+ years in Indian capital markets and IPO research. Subscription data verified before publish.